— Know what they know.
/
Not Investment Advice

RAPP NASDAQ

Rapport Therapeutics, Inc. Common Stock
1W: -5.1% 1M: -33.9% 3M: -16.6% YTD: +14.4% 1Y: +12.2%
$32.17
-0.66 (-2.01%)
 
Weekly Expected Move ±9.7%
$26 $29 $32 $35 $38
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 28 · $1.5B mcap · 23M float · 1.67% daily turnover · Short 52% of daily vol
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain
#156 of 1064
Biotechnology
Healthcare · Small Cap · 264 peers
Market Share
0.1%
Top 4 Concentration: 22.6%

Technical Signal Map

42 Bullish
13 Neutral
210 Bearish
RAPP $1.5B
Rapport Therapeutics, Inc. Common Stock
BEARISH -87
ONTTF $3.0B
Oxford Nanopore Technologies plc
BULLISH +100
MRVI $2.2B
Maravai LifeSciences Holdings, Inc.
BULLISH +100
ABSI $1.9B
Absci Corporation
BULLISH +100
IOVA $6.3B
Iovance Biotherapeutics, Inc.
BULLISH +91
LGND $6.1B
Ligand Pharmaceuticals Incorporated
BULLISH +91
KOD $5.9B
Kodiak Sciences Inc.
BULLISH +91
MANE $4.9B
Veradermics, Incorporated
BULLISH +91
ABCL $4.2B
AbCellera Biologics Inc.
BULLISH +91
PGEN $3.0B
Precigen, Inc.
BULLISH +91
FTRE $1.9B
Fortrea Holdings Inc.
BULLISH +91
NVAX $1.7B
Novavax, Inc.
BULLISH +91
INCPF $2.8B
InnoCare Pharma Limited
BULLISH +87
RXRX $2.2B
Recursion Pharmaceuticals, Inc.
BULLISH +87
AGEN $350M
Agenus Inc.
BULLISH +82
OABIW $2.5B
OmniAb, Inc.
BULLISH +78
DNA $810M
Ginkgo Bioworks Holdings, Inc.
BULLISH +78
YDES $570M
YD Bio Limited Ordinary Shares
BULLISH +78
DMAC $440M
DiaMedica Therapeutics Inc.
BULLISH +78
BVNKF $2.6B
Bavarian Nordic A/S
BULLISH +75
ALMR $2.4B
Alamar Biosciences, Inc.
BULLISH +66
DRTSW $1.6B
Alpha Tau Medical Ltd.
BULLISH +65
TTRX $400M
Turn Therapeutics Inc.
BULLISH +65
OBIO $360M
Orchestra BioMed Holdings, Inc.
BULLISH +65
DMTRF $350M
3-D Matrix, Ltd.
BULLISH +59
ADPT $4.5B
Adaptive Biotechnologies Corporation
BULLISH +58
LKFT $1.9B
Lakefront Biotherapeutics N.V.
BULLISH +58
XERS $1.6B
Xeris Biopharma Holdings, Inc.
BULLISH +58
RIGL $870M
Rigel Pharmaceuticals, Inc.
BULLISH +58
GYRE $790M
Gyre Therapeutics, Inc.
BULLISH +58
GLPGF $2.1B
Lakefront Biotherapeutics
BULLISH +53
PPTDF $940M
PeptiDream Inc.
BULLISH +53
CASBF $1.6B
CanSino Biologics Inc.
BULLISH +51
ADMA $2.2B
ADMA Biologics, Inc.
BULLISH +50
DRTS $1.3B
Alpha Tau Medical Ltd
BULLISH +40
BRCTF $3.3B
BioArctic AB (publ)
BULLISH +35
SYRE $8.1B
Spyre Therapeutics, Inc.
BULLISH +34
STTK $610M
Shattuck Labs, Inc.
BULLISH +34
NTLA $1.7B
Intellia Therapeutics, Inc.
LEAN BULL +27
ENTA $380M
Enanta Pharmaceuticals, Inc.
LEAN BULL +27
VIR $1.9B
Vir Biotechnology, Inc.
LEAN BULL +25
MNKD $1.2B
MannKind Corporation
LEAN BULL +18
VCEL $2.1B
Vericel Corporation
LEAN BULL +10
MAZE $1.5B
Maze Therapeutics, Inc.
NEUTRAL +9
CRSP $5.3B
CRISPR Therapeutics AG
NEUTRAL +8
CAPR $510M
Capricor Therapeutics, Inc.
NEUTRAL +8
PBYI $480M
Puma Biotechnology, Inc.
NEUTRAL +8
CAI $8.0B
Caris Life Sciences, Inc.
NEUTRAL +6
ANL $800M
Adlai Nortye Ltd.
NEUTRAL +5
BCHMF $6.8B
Bachem Holding AG
NEUTRAL +2
OMER $1.4B
Omeros Corporation
NEUTRAL +2
SOLTF $720M
Nxera Pharma Co., Ltd.
NEUTRAL +2
PHMMF $1.6B
Pharma Mar, S.A.
NEUTRAL -3
INRLF $640M
Valneva SE
NEUTRAL -3
VSTM $680M
Verastem, Inc.
NEUTRAL -7
RARE $1.5B
Ultragenyx Pharmaceutical Inc.
NEUTRAL -9
ARQT $3.1B
Arcutis Biotherapeutics, Inc.
LEAN BEAR -11
NVCT $580M
Nuvectis Pharma, Inc.
LEAN BEAR -15
XNCR $1.8B
Xencor, Inc.
LEAN BEAR -16
PROK $580M
ProKidney Corp.
LEAN BEAR -16
TGTX $8.3B
TG Therapeutics, Inc.
LEAN BEAR -18
TNGX $3.8B
Tango Therapeutics, Inc.
LEAN BEAR -18
MDXG $670M
MiMedx Group, Inc.
LEAN BEAR -18
CSPHF $1.2B
CStone Pharmaceuticals
LEAN BEAR -19
GNFTF $790M
Genfit S.a.
LEAN BEAR -20
RLAY $4.2B
Relay Therapeutics, Inc.
LEAN BEAR -23
TBPH $880M
Theravance Biopharma Inc
LEAN BEAR -25
VKTX $3.5B
Viking Therapeutics, Inc.
LEAN BEAR -26
BPMUF $940M
Basilea Pharmaceutica AG
LEAN BEAR -29
ANNX $690M
Annexon, Inc.
BEARISH -31
SNBIF $1.3B
SanBio Company Limited
BEARISH -33
REPL $1.1B
Replimune Group, Inc.
BEARISH -33
SLS $2.2B
SELLAS Life Sciences Group, Inc.
BEARISH -34
CTNM $490M
Contineum Therapeutics, Inc.
BEARISH -35
HNGZY $6.9B
Hangzhou Tigermed Consulting Co., Ltd
BEARISH -38
MDCLF $1.2B
MedinCell S.A.
BEARISH -38
TRSBF $5.4B
3SBio Inc.
BEARISH -40
HRMY $2.3B
Harmony Biosciences Holdings, Inc.
BEARISH -40
PBLS $3.5B
Parabilis Medicines, Inc.
BEARISH -41
MBX $2.8B
MBX Biosciences, Inc. Common Stock
BEARISH -42
NURPF $1.8B
Neuren Pharmaceuticals Limited
BEARISH -42
AVBP $1.3B
ArriVent BioPharma, Inc.
BEARISH -42
SLNCF $570M
Silence Therapeutics plc
BEARISH -42
AVIR $410M
Atea Pharmaceuticals, Inc.
BEARISH -42
PCVX $8.2B
Vaxcyte, Inc.
BEARISH -43
ZLAB $2.8B
Zai Lab Limited
BEARISH -43
NAMSW $2.7B
NewAmsterdam Pharma Company N.V.
BEARISH -43
ORIC $1.3B
ORIC Pharmaceuticals, Inc.
BEARISH -43
SHJBF $4.8B
Shanghai Junshi Biosciences Co., Ltd.
BEARISH -47
IRD $380M
Opus Genetics, Inc.
BEARISH -47
PHGUF $780M
Pharming Group N.V.
BEARISH -49
ERAS $5.1B
Erasca, Inc.
BEARISH -50
ZBIO $1.8B
Zenas BioPharma, Inc.
BEARISH -50
SGP $830M
SpyGlass Pharma, Inc. Common Stock
BEARISH -50
ACHV $740M
Achieve Life Sciences, Inc.
BEARISH -50
VBIZF $400M
Viva Biotech Holdings
BEARISH -52
AVCTF $440M
Avacta Group Plc
BEARISH -53
HNSBF $330M
Hansa Biopharma AB
BEARISH -53
BEAM $2.5B
Beam Therapeutics Inc.
BEARISH -58
JANX $1.0B
Janux Therapeutics, Inc.
BEARISH -58
CBIO $530M
Crescent Biopharma, Inc.
BEARISH -59
EDIT $400M
Editas Medicine, Inc.
BEARISH -59
FGHQF $350M
Frontage Holdings Corporation
BEARISH -60
DFTX $5.0B
Definium Therapeutics, Inc.
BEARISH -62
GHRS $1.6B
GH Research PLC
BEARISH -62
LXRX $810M
Lexicon Pharmaceuticals, Inc.
BEARISH -62
ACRS $610M
Aclaris Therapeutics, Inc.
BEARISH -62
LEGN $3.4B
Legend Biotech Corporation
BEARISH -65
STOK $1.6B
Stoke Therapeutics, Inc.
BEARISH -66
IMTX $1.0B
Immatics N.V.
BEARISH -66
ODTX $1.0B
Odyssey Therapeutics, Inc.
BEARISH -66
SVRA $990M
Savara Inc.
BEARISH -66
DSGN $770M
Design Therapeutics, Inc.
BEARISH -66
RZLT $390M
Rezolute, Inc.
BEARISH -66
OCGN $350M
Ocugen, Inc.
BEARISH -66
TLPPF $3.6B
Telix Pharmaceuticals Limited
BEARISH -68
IDYA $3.5B
IDEAYA Biosciences, Inc.
BEARISH -68
AUPH $2.0B
Aurinia Pharmaceuticals Inc.
BEARISH -68
SEPN $1.7B
Septerna Inc
BEARISH -68
FDMT $710M
4D Molecular Therapeutics, Inc.
BEARISH -68
DNLI $3.2B
Denali Therapeutics Inc.
BEARISH -69
NWPHF $420M
Newron Pharmaceuticals S.p.A.
BEARISH -71
ARCT $370M
Arcturus Therapeutics Holdings Inc.
BEARISH -73
IMVT $6.9B
Immunovant, Inc.
BEARISH -75
CGON $5.9B
CG Oncology Inc.
BEARISH -75
ORKA $5.1B
Oruka Therapeutics, Inc.
BEARISH -75
EWTX $4.5B
Edgewise Therapeutics, Inc.
BEARISH -75
RCUS $3.1B
Arcus Biosciences, Inc.
BEARISH -75
CLDX $2.1B
Celldex Therapeutics, Inc.
BEARISH -75
URGN $2.0B
UroGen Pharma Ltd.
BEARISH -75
BHVN $1.9B
Biohaven Ltd.
BEARISH -75
PVLA $1.9B
Palvella Therapeutics, Inc.
BEARISH -75
TYRA $1.2B
Tyra Biosciences, Inc.
BEARISH -75
VOR $1.0B
Vor Biopharma Inc.
BEARISH -75
SLBT $880M
SL Science Holding Ltd
BEARISH -75
ABUS $880M
Arbutus Biopharma Corp
BEARISH -75
EIKN $400M
Eikon Therapeutics, Inc. Common Stock
BEARISH -75
PRAX $8.2B
Praxis Precision Medicines, Inc.
BEARISH -78
CYTK $8.2B
Cytokinetics, Incorporated
BEARISH -78
SRRK $5.6B
Scholar Rock Holding Corporation
BEARISH -78
DNTH $4.9B
Dianthus Therapeutics, Inc.
BEARISH -78
XENE $3.7B
Xenon Pharmaceuticals Inc.
BEARISH -78
ELVN $3.4B
Enliven Therapeutics, Inc.
BEARISH -78
IDRSF $1.4B
Idorsia Ltd
BEARISH -78
CGEM $950M
Cullinan Therapeutics, Inc.
BEARISH -78
JBIO $860M
Jade Biosciences, Inc.
BEARISH -78
MNPR $520M
Monopar Therapeutics Inc.
BEARISH -78
ASMB $450M
Assembly Biosciences, Inc.
BEARISH -78
AKBLF $6.2B
ALK-Abelló A/S
BEARISH -82
SNDX $1.6B
Syndax Pharmaceuticals, Inc.
BEARISH -82
HBMHF $1.3B
HBM Holdings Limited
BEARISH -82
ARDX $830M
Ardelyx, Inc.
BEARISH -82
KRYS $9.5B
Krystal Biotech, Inc.
BEARISH -84
PTGX $9.0B
Protagonist Therapeutics, Inc.
BEARISH -84
KYMR $8.8B
Kymera Therapeutics, Inc.
BEARISH -84
BLTE $6.4B
Belite Bio, Inc
BEARISH -84
TARS $3.1B
Tarsus Pharmaceuticals, Inc.
BEARISH -84
NRIX $2.4B
Nurix Therapeutics, Inc.
BEARISH -84
PHVS $2.2B
Pharvaris N.V.
BEARISH -84
BCRX $2.1B
BioCryst Pharmaceuticals, Inc.
BEARISH -84
AGIO $1.9B
Agios Pharmaceuticals, Inc.
BEARISH -84
ZYME $1.9B
Zymeworks Inc.
BEARISH -84
NUVB $1.8B
Nuvation Bio Inc.
BEARISH -84
CMPS $1.6B
COMPASS Pathways plc
BEARISH -84
IMCR $1.5B
Immunocore Holdings plc
BEARISH -84
TSHA $1.5B
Taysha Gene Therapies, Inc.
BEARISH -84
INBX $1.4B
Inhibrx Biosciences Inc.
BEARISH -84
NBTX $1.3B
Nanobiotix S.A.
BEARISH -84
KURA $950M
Kura Oncology, Inc.
BEARISH -84
CADL $750M
Candel Therapeutics, Inc.
BEARISH -84
ZVRA $590M
Zevra Therapeutics, Inc.
BEARISH -84
PRME $540M
Prime Medicine, Inc.
BEARISH -84
AUTL $470M
Autolus Therapeutics plc
BEARISH -84
OVID $440M
Ovid Therapeutics Inc.
BEARISH -84
NGNE $410M
Neurogene Inc.
BEARISH -84
CCCC $330M
C4 Therapeutics, Inc.
BEARISH -84
AXSM $9.2B
Axsome Therapeutics, Inc.
BEARISH -87
ARWR $9.0B
Arrowhead Pharmaceuticals, Inc.
BEARISH -87
RYTM $6.4B
Rhythm Pharmaceuticals, Inc.
BEARISH -87
REGMF $5.6B
RemeGen Co., Ltd.
BEARISH -87
TVTX $5.3B
Travere Therapeutics, Inc.
BEARISH -87
ACAD $3.4B
Acadia Pharmaceuticals Inc.
BEARISH -87
AMLX $3.1B
Amylyx Pharmaceuticals, Inc.
BEARISH -87
DYN $2.8B
Dyne Therapeutics, Inc.
BEARISH -87
IRON $2.5B
Disc Medicine, Inc.
BEARISH -87
IMNM $2.0B
Immunome, Inc.
BEARISH -87
TRVI $2.0B
Trevi Therapeutics, Inc.
BEARISH -87
QURE $1.6B
uniQure N.V.
BEARISH -87
OCUL $1.5B
Ocular Therapeutix, Inc.
BEARISH -87
ANAB $1.4B
AnaptysBio, Inc.
BEARISH -87
NKTR $1.2B
Nektar Therapeutics
BEARISH -87
BCAX $1.2B
Bicara Therapeutics Inc. Common Stock
BEARISH -87
LBRX $1.1B
LB Pharmaceuticals Inc Common Stock
BEARISH -87
MGTX $1.0B
MeiraGTx Holdings plc
BEARISH -87
AKTS $990M
Aktis Oncology, Inc.
BEARISH -87
ANRO $870M
Alto Neuroscience, Inc.
BEARISH -87
AVTX $790M
Avalo Therapeutics, Inc.
BEARISH -87
SLDB $670M
Solid Biosciences Inc.
BEARISH -87
AURA $630M
Aura Biosciences, Inc.
BEARISH -87
CLYM $630M
Climb Bio, Inc.
BEARISH -87
IMMX $530M
Immix Biopharma, Inc.
BEARISH -87
TECX $430M
Tectonic Therapeutic, Inc.
BEARISH -87
FENC $350M
Fennec Pharmaceuticals Inc.
BEARISH -87
ARTV $330M
Artiva Biotherapeutics, Inc.
BEARISH -87
BRVE $1.5B
Braveheart Bio, Inc.
BEARISH -90
APMD $860M
Apnimed, Inc.
BEARISH -90
PTCT $5.3B
PTC Therapeutics, Inc.
BEARISH -91
CAMRF $3.7B
Camurus AB
BEARISH -91
ZLDPF $2.8B
Zealand Pharma A/S
BEARISH -91
VERA $2.2B
Vera Therapeutics, Inc.
BEARISH -91
GENSF $1.9B
Genus plc
BEARISH -91
COAG $1.4B
Hemab Therapeutics Holdings, Inc. Common Stock
BEARISH -91
KLRA $1.4B
Kailera Therapeutics, Inc.
BEARISH -91
KARD $1.3B
Kardigan, Inc.
BEARISH -91
AVLN $1.2B
Avalyn Pharma Inc. Common Stock
BEARISH -91
SPTX $990M
Seaport Therapeutics, Inc. Common Stock
BEARISH -91
MLTX $960M
MoonLake Immunotherapeutics
BEARISH -91
WVE $740M
Wave Life Sciences Ltd.
BEARISH -91
FTH $730M
Faeth Therapeutics, Inc.
BEARISH -91
OCS $500M
Oculis Holding AG
BEARISH -91
DRUG $500M
Bright Minds Biosciences Inc.
BEARISH -91
PRTA $440M
Prothena Corporation plc
BEARISH -91
MPLT $420M
MapLight Therapeutics, Inc.
BEARISH -91
ZURA $390M
Zura Bio Limited
BEARISH -91
CABA $330M
Cabaletta Bio, Inc.
BEARISH -91
BBOT $310M
BridgeBio Oncology Therapeutics Inc.
BEARISH -91
IONS $7.2B
Ionis Pharmaceuticals, Inc.
BEARISH -100
COGT $5.3B
Cogent Biosciences, Inc.
BEARISH -100
MIRM $5.1B
Mirum Pharmaceuticals, Inc.
BEARISH -100
CELC $3.5B
Celcuity Inc.
BEARISH -100
VCRE $2.6B
Vicore Pharma Holding AB
BEARISH -100
VRDN $2.2B
Viridian Therapeutics, Inc.
BEARISH -100
MLYS $2.1B
Mineralys Therapeutics, Inc.
BEARISH -100
SRPT $1.9B
Sarepta Therapeutics, Inc.
BEARISH -100
MESO $1.8B
Mesoblast Limited
BEARISH -100
GENB $1.8B
Generate Biomedicines, Inc.
BEARISH -100
GPCR $1.6B
Structure Therapeutics Inc.
BEARISH -100
INVA $1.5B
Innoviva, Inc.
BEARISH -100
ASPHF $1.4B
Ascentage Pharma Group International
BEARISH -100
DMRA $1.3B
Damora Therapeutics, Inc.
BEARISH -100
TRAX $1.2B
First Tracks Biotherapeutics Inc
BEARISH -100
ASCLF $1.1B
Ascletis Pharma Inc.
BEARISH -100
CRVS $920M
Corvus Pharmaceuticals, Inc.
BEARISH -100
GLUE $890M
Monte Rosa Therapeutics, Inc.
BEARISH -100
ALMS $850M
Alumis Inc.
BEARISH -100
SANA $800M
Sana Biotechnology, Inc.
BEARISH -100
GERN $770M
Geron Corporation
BEARISH -100
IVEVF $760M
Inventiva S.A.
BEARISH -100
ATTO $740M
Attovia Therapeutics, Inc.
BEARISH -100
OLMA $720M
Olema Pharmaceuticals, Inc.
BEARISH -100
BLSM $570M
BlossomHill Therapeutics, Inc.
BEARISH -100
PHAT $560M
Phathom Pharmaceuticals, Inc.
BEARISH -100
CTMX $560M
CytomX Therapeutics, Inc.
BEARISH -100
CRMD $560M
CorMedix Inc.
BEARISH -100
ALT $530M
Altimmune, Inc.
BEARISH -100
ALLO $520M
Allogene Therapeutics, Inc.
BEARISH -100
ARVN $480M
Arvinas, Inc.
BEARISH -100
AGMB $420M
AgomAb Therapeutics N.V. American Depositary Shares
BEARISH -100
SPRY $400M
ARS Pharmaceuticals, Inc.
BEARISH -100
RLMD $380M
Relmada Therapeutics, Inc.
BEARISH -100
KYTX $380M
Kyverna Therapeutics, Inc.
BEARISH -100
RGNX $380M
REGENXBIO Inc.
BEARISH -100
PTCHF $380M
PureTech Health plc
BEARISH -100
BNTC $310M
Benitec Biopharma Inc.
BEARISH -100
LRMR $310M
Larimar Therapeutics, Inc.
BEARISH -100

Peer Comparison

Symbol Mkt Cap P/E ROE % ROIC % Net Mgn % Rev Grw % Piotroski Signal 1Y Ret %
RAPP Rapport Therapeutics, Inc. Common Stock $1.5B -10.6 -40.0 3981.5 — — 4 BEARISH 12.2
ONTTF Oxford Nanopore Technologies plc $3.0B -14.0 -52.9 -79.5 -41.1 33.0 3 BULLISH 39.5
MRVI Maravai LifeSciences Holdings, Inc. $2.2B -14.8 -32.9 24.4 -24.1 -3.3 5 BULLISH 151.6
ABSI Absci Corporation $1.9B -13.8 -57.7 -213.1 -10443.4 -62.3 5 BULLISH 253.7
IOVA Iovance Biotherapeutics, Inc. $6.3B -20.3 -40.4 -49.1 -47.6 34.5 6 BULLISH 543.4
LGND Ligand Pharmaceuticals Incorporated $6.1B 30.3 22.0 11.3 76.2 54.9 5 BULLISH 69.2
KOD Kodiak Sciences Inc. $5.9B -22.5 -368.4 -630.1 — — 1 BULLISH 499.3
MANE Veradermics, Incorporated $4.9B — — — — — — BULLISH —
ABCL AbCellera Biologics Inc. $4.2B -25.4 -17.3 -36.2 -1368.6 101.3 4 BULLISH 130.5
PGEN Precigen, Inc. $3.0B -7.5 -4640.4 -30.1 36.5 1875.0 5 BULLISH 155.7
FTRE Fortrea Holdings Inc. $1.9B -21.5 -15.3 0.6 -1.9 -2.1 6 BULLISH 110.1
NVAX Novavax, Inc. $1.7B -6.9 323.7 29.2 -94.2 -61.6 2 BULLISH 10.1
INCPF InnoCare Pharma Limited $2.8B 22.4 12.6 127.0 23.1 108.5 5 BULLISH -43.2
RXRX Recursion Pharmaceuticals, Inc. $2.2B -4.0 -56.6 -99.7 -1708.0 -14.9 4 BULLISH -19.2
AGEN Agenus Inc. $350M 3.1 -33.2 -20.4 -1.6 30.5 6 BULLISH 114.4
OABIW OmniAb, Inc. $2.5B -13.5 -16.9 -16.8 -43.7 66.9 6 BULLISH -9.3
DNA Ginkgo Bioworks Holdings, Inc. $810M -2.5 -56.3 -44.0 -231.7 -51.5 2 BULLISH -15.9
YDES YD Bio Limited Ordinary Shares $570M — — — — — — BULLISH -54.7
DMAC DiaMedica Therapeutics Inc. $440M -11.4 -114.6 616.3 — — 2 BULLISH 20.0
BVNKF Bavarian Nordic A/S $2.6B 11.0 12.2 13.3 36.0 -2.6 7 BULLISH -7.3
ALMR Alamar Biosciences, Inc. $2.4B — — — — — — BULLISH —
DRTSW Alpha Tau Medical Ltd. $1.6B -14.2 -141.7 -17.1 — — 3 BULLISH 1253.3
TTRX Turn Therapeutics Inc. $400M -45.7 -952.4 115.0 — — 2 BULLISH —
OBIO Orchestra BioMed Holdings, Inc. $360M -6.0 -397.3 468.3 -26994.3 986.1 4 BULLISH 133.3
DMTRF 3-D Matrix, Ltd. $350M 13.8 92.3 29.3 50.9 56.9 5 BULLISH 80.0
ADPT Adaptive Biotechnologies Corporation $4.5B -69.6 -39.6 -14.1 -55.6 50.1 5 BULLISH 94.7
LKFT Lakefront Biotherapeutics N.V. $1.9B — — — — — — BULLISH —
XERS Xeris Biopharma Holdings, Inc. $1.6B -93.5 118.2 18.3 -33.8 36.3 6 BULLISH 13.4
RIGL Rigel Pharmaceuticals, Inc. $870M 2.7 126.9 88.5 22.0 3.3 4 BULLISH 67.4
GYRE Gyre Therapeutics, Inc. $790M -35.7 -15.6 -22.3 -36.4 16.8 3 BULLISH -6.2
GLPGF Lakefront Biotherapeutics $2.1B 3.5 20.2 39.4 17.4 259.3 5 BULLISH -4.5
PPTDF PeptiDream Inc. $940M -38.3 -7.1 -9.6 -25.7 47.8 4 BULLISH -34.3
CASBF CanSino Biologics Inc. $1.6B 523.4 0.8 -1.2 11.0 32.5 7 BULLISH -29.6
ADMA ADMA Biologics, Inc. $2.2B 13.5 41.9 35.5 30.4 8.0 5 BULLISH -35.4
DRTS Alpha Tau Medical Ltd $1.3B -14.2 -141.7 -17.1 — — 3 BULLISH 238.0
BRCTF BioArctic AB (publ) $3.3B 256.5 5.2 77.4 -4.5 -46.1 3 BULLISH 17.6
SYRE Spyre Therapeutics, Inc. $8.1B -47.8 -23.0 359.8 — — 3 BULLISH 466.2
STTK Shattuck Labs, Inc. $610M -13.2 -39.2 -29.3 — -66.6 4 BULLISH 182.8
NTLA Intellia Therapeutics, Inc. $1.7B -3.6 -55.4 -92.1 -1392.3 12.6 4 LEAN BULL -34.6
ENTA Enanta Pharmaceuticals, Inc. $380M -5.4 -70.1 141.5 -135.8 0.7 4 LEAN BULL 22.1
VIR Vir Biotechnology, Inc. $1.9B -6.0 -26.1 -38.9 33.5 1495.9 4 LEAN BULL 96.0
MNKD MannKind Corporation $1.2B -27.2 71.4 4.0 -17.4 30.5 2 LEAN BULL -29.4
VCEL Vericel Corporation $2.1B 83.6 7.2 5.9 2.8 23.0 7 LEAN BULL 29.9
MAZE Maze Therapeutics, Inc. $1.5B -9.6 -37.3 -112.3 — — 3 NEUTRAL 2.4
CRSP CRISPR Therapeutics AG $5.3B -11.6 -26.1 -253.2 -895.3 -62.7 2 NEUTRAL -16.2
CAPR Capricor Therapeutics, Inc. $510M -3.7 -73.7 -107.5 — -100.0 3 NEUTRAL 14.4
PBYI Puma Biotechnology, Inc. $480M 17.7 22.0 52.8 14.5 -2.9 6 NEUTRAL 80.5
CAI Caris Life Sciences, Inc. $8.0B 76.1 20.1 61.1 -0.2 445.5 7 NEUTRAL -6.7
ANL Adlai Nortye Ltd. $800M -7.7 -22.4 -317.5 -36.3 223.4 4 NEUTRAL 738.3
BCHMF Bachem Holding AG $6.8B 39.8 20.6 17.5 15.4 24.3 6 NEUTRAL 48.1
OMER Omeros Corporation $1.4B 9.7 -89.2 71.8 46.4 — 5 NEUTRAL 349.5
SOLTF Nxera Pharma Co., Ltd. $720M -14.1 -12.0 -1.7 -2.6 7.5 4 NEUTRAL 22.2
PHMMF Pharma Mar, S.A. $1.6B 21.9 24.9 35.9 -2.0 15.5 7 NEUTRAL -7.5
INRLF Valneva SE $640M -2.8 -118.0 -54.8 -89.3 -27.2 1 NEUTRAL -31.5
VSTM Verastem, Inc. $680M -3.1 -471.2 6197.3 -86.5 3995.7 4 NEUTRAL -12.5
RARE Ultragenyx Pharmaceutical Inc. $1.5B -2.6 839.4 -67.5 -43.0 17.5 2 NEUTRAL -49.2
ARQT Arcutis Biotherapeutics, Inc. $3.1B 113.9 15.9 34.7 11.6 76.1 7 LEAN BEAR 27.3
NVCT Nuvectis Pharma, Inc. $580M -16.7 -214.6 174.4 — — 1 LEAN BEAR 261.7
XNCR Xencor, Inc. $1.8B -11.4 -29.1 -152.4 -42.4 -36.1 2 LEAN BEAR 110.0
PROK ProKidney Corp. $580M -3.0 9.2 13.2 -18948.0 55.2 1 LEAN BEAR -33.9
TGTX TG Therapeutics, Inc. $8.3B 17.8 100.3 73.5 3.2 76.1 5 LEAN BEAR 48.5
TNGX Tango Therapeutics, Inc. $3.8B -27.3 -21.3 -253.2 — 121.5 3 LEAN BEAR 191.2
MDXG MiMedx Group, Inc. $670M 114.8 2.9 5.8 -23.1 -2.4 6 LEAN BEAR -32.8
CSPHF CStone Pharmaceuticals $1.2B -17.9 -74.4 -553.0 -123.0 -36.4 4 LEAN BEAR -24.5
GNFTF Genfit S.a. $790M -4.5 -575.3 -453.0 -124.0 1.4 4 LEAN BEAR 323.4
RLAY Relay Therapeutics, Inc. $4.2B -12.1 -36.8 -2519.7 -23916.3 23.9 4 LEAN BEAR 256.4
TBPH Theravance Biopharma Inc $880M 16.0 20.9 -7.2 -28.5 35.1 7 LEAN BEAR 21.2
VKTX Viking Therapeutics, Inc. $3.5B -6.4 -88.9 495.6 — — 1 LEAN BEAR 9.4
BPMUF Basilea Pharmaceutica AG $940M 15.7 140.1 185.7 23.5 49.5 9 LEAN BEAR 12.6
ANNX Annexon, Inc. $690M -3.6 -105.3 -11323.3 — — 2 BEARISH 38.3
SNBIF SanBio Company Limited $1.3B -19.7 -50.0 1250.3 — — 4 BEARISH 0.0
REPL Replimune Group, Inc. $1.1B -4.1 -107.9 -2853.5 — — 1 BEARISH 210.4
SLS SELLAS Life Sciences Group, Inc. $2.2B -55.6 -39.6 55646.0 — — 4 BEARISH 594.7
CTNM Contineum Therapeutics, Inc. $490M -7.6 -28.0 -541.6 — — 4 BEARISH 19.2
HNGZY Hangzhou Tigermed Consulting Co., Ltd $6.9B 730.0 0.5 1.6 -24.2 12.0 6 BEARISH 11.2
MDCLF MedinCell S.A. $1.2B -24.4 264.0 116.8 -152.1 129.2 6 BEARISH 392.7
TRSBF 3SBio Inc. $5.4B 4.1 50.1 99.1 25.3 66.8 7 BEARISH -38.6
HRMY Harmony Biosciences Holdings, Inc. $2.3B 12.7 20.5 35.7 28.9 24.3 5 BEARISH 47.2
PBLS Parabilis Medicines, Inc. $3.5B — — — — — — BEARISH —
MBX MBX Biosciences, Inc. Common Stock $2.8B -24.4 -33.2 1634.0 — — 2 BEARISH 226.9
NURPF Neuren Pharmaceuticals Limited $1.8B 128.1 61.3 282.5 14.6 7.2 5 BEARISH 19.0
AVBP ArriVent BioPharma, Inc. $1.3B -7.7 -53.1 2345.1 — — 3 BEARISH 53.1
SLNCF Silence Therapeutics plc $570M -2.8 -90.4 137.0 — -97.6 1 BEARISH 175.9
AVIR Atea Pharmaceuticals, Inc. $410M -2.5 -58.1 974.6 — — 3 BEARISH 78.1
PCVX Vaxcyte, Inc. $8.2B -7.4 -36.5 -66.4 — — 0 BEARISH 48.5
ZLAB Zai Lab Limited $2.8B -14.4 -26.9 -85.4 -47.8 5.1 3 BEARISH -29.4
NAMSW NewAmsterdam Pharma Company N.V. $2.7B -10.6 -36.8 8216.2 -1732.9 -88.9 2 BEARISH -26.1
ORIC ORIC Pharmaceuticals, Inc. $1.3B -9.0 -39.8 -102.9 — — 3 BEARISH 4.3
SHJBF Shanghai Junshi Biosciences Co., Ltd. $4.8B -83.2 -7.1 -6.3 4.4 29.7 5 BEARISH -14.8
IRD Opus Genetics, Inc. $380M -3.6 -4796.5 59.8 -1072.6 -36.1 3 BEARISH 154.4
PHGUF Pharming Group N.V. $780M 66.6 3.7 5.8 1.7 7.8 7 BEARISH -26.0
ERAS Erasca, Inc. $5.1B -15.5 -78.2 -87.5 — — 2 BEARISH 567.0
ZBIO Zenas BioPharma, Inc. $1.8B -2.9 -199.0 5842.1 -11145.6 -93.3 2 BEARISH 27.9
SGP SpyGlass Pharma, Inc. Common Stock $830M — — — — — — BEARISH —
ACHV Achieve Life Sciences, Inc. $740M -4.7 -845.0 24.6 — — 2 BEARISH 133.6
VBIZF Viva Biotech Holdings $400M 15.4 9.0 8.9 8.0 -15.5 5 BEARISH -31.6
AVCTF Avacta Group Plc $440M -7.9 -553.3 -1587.8 -33970.3 -65.3 2 BEARISH 25.6
HNSBF Hansa Biopharma AB $330M -4.2 159.8 1182.7 -541.7 -3.7 2 BEARISH 9.7
BEAM Beam Therapeutics Inc. $2.5B -29.9 -8.1 -184.5 -25036.3 158.9 4 BEARISH 1.5
JANX Janux Therapeutics, Inc. $1.0B -10.3 -10.7 516.9 -214.0 7162.0 4 BEARISH -28.6
CBIO Crescent Biopharma, Inc. $530M -1.9 -107.7 1928.6 — — 5 BEARISH 20.3
EDIT Editas Medicine, Inc. $400M -3.5 -118.8 71.4 -153.3 20.8 4 BEARISH -26.2
FGHQF Frontage Holdings Corporation $350M 28.9 4.2 4.5 4.6 2.1 6 BEARISH 16.8
DFTX Definium Therapeutics, Inc. $5.0B -10.9 -25.7 82.4 — — 2 BEARISH —
GHRS GH Research PLC $1.6B -22.9 -18.8 2015.5 — — 2 BEARISH 69.0
LXRX Lexicon Pharmaceuticals, Inc. $810M -12.1 -40.2 -99.7 -4591.8 -29.0 3 BEARISH 59.6
ACRS Aclaris Therapeutics, Inc. $610M -7.6 -59.1 -206.5 -1320.1 -51.0 3 BEARISH 134.8
LEGN Legend Biotech Corporation $3.4B -37.1 -8.1 -8.2 8.6 59.5 4 BEARISH -43.1
STOK Stoke Therapeutics, Inc. $1.6B -7.6 -61.1 -318.5 -660.8 -86.2 2 BEARISH 8.6
IMTX Immatics N.V. $1.0B -4.2 -47.8 -858.3 -683.4 -68.0 2 BEARISH -15.7
ODTX Odyssey Therapeutics, Inc. $1.0B — — — — — — BEARISH —
SVRA Savara Inc. $990M -8.3 -105.5 -15438.9 — — 2 BEARISH 35.9
DSGN Design Therapeutics, Inc. $770M -10.5 -34.1 1787.8 — — 1 BEARISH 81.7
RZLT Rezolute, Inc. $390M -5.3 -59.0 1060.6 — — 2 BEARISH -57.5
OCGN Ocugen, Inc. $350M -4.0 1211.7 190.2 -1671.8 -3.7 2 BEARISH -39.3
TLPPF Telix Pharmaceuticals Limited $3.6B 109.7 14.8 5.8 8.0 201.7 5 BEARISH 15.3
IDYA IDEAYA Biosciences, Inc. $3.5B -19.5 -16.2 -42.9 -1269.6 3244.7 3 BEARISH 36.5
AUPH Aurinia Pharmaceuticals Inc. $2.0B 6.7 66.1 127.2 45.0 19.8 7 BEARISH 38.9
SEPN Septerna Inc $1.7B -69.8 -6.3 -93.1 -48.7 17878.5 5 BEARISH 98.5
FDMT 4D Molecular Therapeutics, Inc. $710M -5.0 -43.3 -182.0 -1929.0 278712.1 4 BEARISH 56.6
DNLI Denali Therapeutics Inc. $3.2B -7.0 -54.9 -281.7 -3539.2 — 3 BEARISH 34.1
NWPHF Newron Pharmaceuticals S.p.A. $420M -6.0 83.9 -32.1 -513.4 — 1 BEARISH —
ARCT Arcturus Therapeutics Holdings Inc. $370M -3.9 -46.3 -2501.0 -803.8 -79.1 1 BEARISH -36.4
IMVT Immunovant, Inc. $6.9B -11.9 -64.8 851.4 — — 2 BEARISH 105.8
CGON CG Oncology Inc. $5.9B -25.0 -26.4 -2066.1 -6832.8 1030.3 3 BEARISH 70.8
ORKA Oruka Therapeutics, Inc. $5.1B -34.2 -18.2 -50.3 — — 4 BEARISH 353.9
EWTX Edgewise Therapeutics, Inc. $4.5B -22.4 -38.0 1912.5 — — 1 BEARISH 168.1
RCUS Arcus Biosciences, Inc. $3.1B -6.2 -89.2 309.6 -222.0 -55.3 0 BEARISH 81.5
CLDX Celldex Therapeutics, Inc. $2.1B -7.3 -43.9 -13685.9 -334104.5 -98.1 1 BEARISH 25.1
URGN UroGen Pharma Ltd. $2.0B -20.9 86.5 119.0 -19.8 169.5 2 BEARISH 132.3
BHVN Biohaven Ltd. $1.9B -2.8 -799.5 -1083.0 — — 3 BEARISH -13.1
PVLA Palvella Therapeutics, Inc. $1.9B -27.4 -46.6 137.5 — — 3 BEARISH 109.5
TYRA Tyra Biosciences, Inc. $1.2B -8.5 -45.3 -2390.9 — — 2 BEARISH 52.2
VOR Vor Biopharma Inc. $1.0B -0.1 -73.6 22.2 — — 3 BEARISH -52.4
SLBT SL Science Holding Ltd $880M — — — — — — BEARISH —
ABUS Arbutus Biopharma Corp $880M 5.6 89.6 86.7 -507.2 1078.8 4 BEARISH -3.0
EIKN Eikon Therapeutics, Inc. Common Stock $400M — — — — — — BEARISH —
PRAX Praxis Precision Medicines, Inc. $8.2B -22.8 -38.9 -51.2 — -100.0 4 BEARISH 457.4
CYTK Cytokinetics, Incorporated $8.2B -9.1 329.8 811.2 -622.8 -17.2 2 BEARISH 17.5
SRRK Scholar Rock Holding Corporation $5.6B -14.1 -167.8 931.3 — — 2 BEARISH 35.0
DNTH Dianthus Therapeutics, Inc. $4.9B -678.5 -4.1 -60.1 -6598.6 -60.8 3 BEARISH 126.6
XENE Xenon Pharmaceuticals Inc. $3.7B -8.0 -43.6 -109.7 — -100.0 3 BEARISH -2.8
ELVN Enliven Therapeutics, Inc. $3.4B -28.6 -15.3 -6535.0 — — 3 BEARISH 136.9
IDRSF Idorsia Ltd $1.4B -3.4 27.1 -344.5 -203.1 -8.1 1 BEARISH 17.0
CGEM Cullinan Therapeutics, Inc. $950M -4.6 -50.3 1635.6 — — 1 BEARISH 158.5
JBIO Jade Biosciences, Inc. $860M -5.1 -47.8 629.9 — — 3 BEARISH 55.0
MNPR Monopar Therapeutics Inc. $520M -33.3 -19.5 523.8 — — 2 BEARISH -8.0
ASMB Assembly Biosciences, Inc. $450M 41.0 -0.0 56.2 -28.8 125.1 4 BEARISH -8.4
AKBLF ALK-Abelló A/S $6.2B 33.0 21.2 23.9 18.9 16.4 8 BEARISH 7.1
SNDX Syndax Pharmaceuticals, Inc. $1.6B -7.0 -255.9 -270.9 -67.8 222.3 4 BEARISH 12.2
HBMHF HBM Holdings Limited $1.3B 17.0 58.2 96.1 53.0 133.3 6 BEARISH -8.8
ARDX Ardelyx, Inc. $830M -14.8 -38.6 -22.7 -13.8 16.8 4 BEARISH -37.7
KRYS Krystal Biotech, Inc. $9.5B 39.0 20.1 40.4 45.9 22.6 7 BEARISH 79.4
PTGX Protagonist Therapeutics, Inc. $9.0B 115.0 11.0 84.1 76.3 34.8 7 BEARISH 118.8
KYMR Kymera Therapeutics, Inc. $8.8B -33.0 -24.2 -30.7 -94.2 134.8 6 BEARISH 96.5
BLTE Belite Bio, Inc $6.4B -57.8 -20.8 -11.5 — — 3 BEARISH 117.1
TARS Tarsus Pharmaceuticals, Inc. $3.1B -67.0 -13.7 268.1 -10.7 105.2 5 BEARISH 27.3
NRIX Nurix Therapeutics, Inc. $2.4B -6.7 -80.3 -1655.0 -990.1 -58.4 2 BEARISH 144.6
PHVS Pharvaris N.V. $2.2B -10.3 -70.7 860.9 — — 4 BEARISH 29.6
BCRX BioCryst Pharmaceuticals, Inc. $2.1B -5.7 87.8 62.3 35.9 68.7 5 BEARISH 10.8
AGIO Agios Pharmaceuticals, Inc. $1.9B -4.5 -34.3 -82.5 -225.1 140.6 4 BEARISH -20.6
ZYME Zymeworks Inc. $1.9B -12.5 -72.3 -156.9 -980.8 -69.8 2 BEARISH 48.5
NUVB Nuvation Bio Inc. $1.8B -11.8 -47.8 70.2 -198.3 1083.6 4 BEARISH 38.6
CMPS COMPASS Pathways plc $1.6B -2.1 -319.1 48.8 — — 2 BEARISH 106.2
IMCR Immunocore Holdings plc $1.5B -164.8 -2.3 -472.0 -0.7 13.4 4 BEARISH -17.3
TSHA Taysha Gene Therapies, Inc. $1.5B -11.0 -47.1 961.0 — -32.3 3 BEARISH 45.6
INBX Inhibrx Biosciences Inc. $1.4B -10.9 -1773.6 55.8 — -100.0 4 BEARISH 185.4
NBTX Nanobiotix S.A. $1.3B -20.8 380.7 158.8 -941.2 -73.7 3 BEARISH 37.4
KURA Kura Oncology, Inc. $950M -3.2 -167.7 56.3 -327.3 -7.3 1 BEARISH 15.8
CADL Candel Therapeutics, Inc. $750M -7.2 -81.8 219.4 — — 2 BEARISH 83.8
ZVRA Zevra Therapeutics, Inc. $590M 10.4 34.8 -1356.4 22.1 119.4 6 BEARISH 5.9
PRME Prime Medicine, Inc. $540M -2.7 -373.3 -271.3 -3649.0 -17.9 3 BEARISH -46.7
AUTL Autolus Therapeutics plc $470M -1.7 -132.9 451.5 -85.6 292.0 3 BEARISH 6.6
OVID Ovid Therapeutics Inc. $440M -5.0 -26.0 -43.7 -2047.6 -76.2 3 BEARISH 73.7
NGNE Neurogene Inc. $410M -4.7 -45.3 -111469.0 — — 2 BEARISH 42.7
CCCC C4 Therapeutics, Inc. $330M -3.0 -48.1 -175.0 -355.9 2.3 4 BEARISH 37.2
AXSM Axsome Therapeutics, Inc. $9.2B -47.8 -245.1 859.1 -23.5 56.9 5 BEARISH 51.2
ARWR Arrowhead Pharmaceuticals, Inc. $9.0B -28.7 -64.8 65.7 -258.2 12.2 4 BEARISH 83.3
RYTM Rhythm Pharmaceuticals, Inc. $6.4B -29.8 -200.0 144.2 -69.2 53.5 4 BEARISH -7.2
REGMF RemeGen Co., Ltd. $5.6B 11.3 108.3 139.6 83.4 283.6 7 BEARISH 96.8
TVTX Travere Therapeutics, Inc. $5.3B -126.5 -151.8 -21.0 -20.5 77.1 6 BEARISH 129.7
ACAD Acadia Pharmaceuticals Inc. $3.4B 8.9 35.7 63.9 10.2 11.8 5 BEARISH -6.1
AMLX Amylyx Pharmaceuticals, Inc. $3.1B -19.7 -74.7 2020.5 — 100.0 5 BEARISH 98.5
DYN Dyne Therapeutics, Inc. $2.8B -4.6 -81.6 240.4 — — 2 BEARISH 21.6
IRON Disc Medicine, Inc. $2.5B -9.8 -39.1 1672.3 — — 1 BEARISH -3.8
IMNM Immunome, Inc. $2.0B -8.2 -64.0 -2208.4 — -100.0 4 BEARISH 84.3
TRVI Trevi Therapeutics, Inc. $2.0B -41.2 -19.7 -1451.7 — — 3 BEARISH 48.0
QURE uniQure N.V. $1.6B -5.8 -157.6 37.9 -1387.8 30.2 4 BEARISH -57.3
OCUL Ocular Therapeutix, Inc. $1.5B -4.9 -73.0 -31671.3 -584.5 -8.1 3 BEARISH -37.0
ANAB AnaptysBio, Inc. $1.4B 7.2 -1146.3 466.0 668.9 92.9 5 BEARISH 127.7
NKTR Nektar Therapeutics $1.2B -6.5 -35.8 -29.2 -401.0 -27.2 3 BEARISH -25.9
BCAX Bicara Therapeutics Inc. Common Stock $1.2B -5.7 -41.0 583.9 — — 2 BEARISH 6.1
LBRX LB Pharmaceuticals Inc Common Stock $1.1B -12.5 -25.8 -768.9 — — 2 BEARISH 134.7
MGTX MeiraGTx Holdings plc $1.0B 14.2 72.3 96.7 50.0 948.3 7 BEARISH 30.5
AKTS Aktis Oncology, Inc. $990M -17.6 -29.9 276.4 -713.5 -36.1 5 BEARISH 18875.4
ANRO Alto Neuroscience, Inc. $870M -10.0 -49.2 -201.4 — — 3 BEARISH 509.6
AVTX Avalo Therapeutics, Inc. $790M -3.2 -36.3 -148.4 — -86.6 4 BEARISH 15.7
SLDB Solid Biosciences Inc. $670M -3.6 -65.5 -1012.6 — — 3 BEARISH 16.7
AURA Aura Biosciences, Inc. $630M -3.4 -53.5 -1360.0 — — 4 BEARISH -1.0
CLYM Climb Bio, Inc. $630M -13.2 -27.1 -88.6 — — 2 BEARISH 455.3
IMMX Immix Biopharma, Inc. $530M -11.0 -34.2 1509.2 — — 4 BEARISH 365.4
TECX Tectonic Therapeutic, Inc. $430M -4.9 -33.8 -6371.3 — — 1 BEARISH 43.9
FENC Fennec Pharmaceuticals Inc. $350M -78.5 -18.6 -76.2 11.0 77.8 6 BEARISH 6.4
ARTV Artiva Biotherapeutics, Inc. $330M -2.1 -36.6 -954.6 — — 3 BEARISH 133.9
BRVE Braveheart Bio, Inc. $1.5B — — — — — — BEARISH —
APMD Apnimed, Inc. $860M — — — — — — BEARISH —
PTCT PTC Therapeutics, Inc. $5.3B -129.5 20.6 -5.4 23.2 -42.8 2 BEARISH 2.3
CAMRF Camurus AB $3.7B 53.4 15.8 89.3 34.3 -0.2 6 BEARISH -10.3
ZLDPF Zealand Pharma A/S $2.8B 6.8 16.3 57.2 87.2 -49.2 3 BEARISH -47.9
VERA Vera Therapeutics, Inc. $2.2B -5.2 -91.8 2030.6 — — 1 BEARISH 5.7
GENSF Genus plc $1.9B 5.0 45.8 14.4 80.4 28.9 7 BEARISH -17.7
COAG Hemab Therapeutics Holdings, Inc. Common Stock $1.4B — — — — — — BEARISH —
KLRA Kailera Therapeutics, Inc. $1.4B — — — — — — BEARISH —
KARD Kardigan, Inc. $1.3B — — — — — — BEARISH —
AVLN Avalyn Pharma Inc. Common Stock $1.2B — — — — — — BEARISH —
SPTX Seaport Therapeutics, Inc. Common Stock $990M — — — — — — BEARISH —
MLTX MoonLake Immunotherapeutics $960M -3.0 -67.4 2902.7 — — 1 BEARISH 61.6
WVE Wave Life Sciences Ltd. $740M -3.5 -68.3 -2645.3 -3052.6 -30.4 5 BEARISH -46.2
FTH Faeth Therapeutics, Inc. $730M — — — — — — BEARISH —
OCS Oculis Holding AG $500M -5.2 -44.0 -31.0 — -6.9 3 BEARISH -49.8
DRUG Bright Minds Biosciences Inc. $500M -24.3 -13.7 -105758.3 — — 3 BEARISH -12.5
PRTA Prothena Corporation plc $440M -10.1 -14.4 -871.5 -1839.9 427.3 5 BEARISH -15.7
MPLT MapLight Therapeutics, Inc. $420M -1.9 -57.5 -366.6 — — 2 BEARISH —
ZURA Zura Bio Limited $390M -3.6 -54.3 910.3 — — 2 BEARISH 1.7
CABA Cabaletta Bio, Inc. $330M -1.3 -93.2 -1308.0 — — 3 BEARISH -13.4
BBOT BridgeBio Oncology Therapeutics Inc. $310M -0.0 -56.4 -157.3 — — 1 BEARISH -67.7
IONS Ionis Pharmaceuticals, Inc. $7.2B -12.6 -105.4 -58.5 -42.8 -7.4 3 BEARISH -33.8
COGT Cogent Biosciences, Inc. $5.3B -13.4 -109.7 1964.0 — — 3 BEARISH 119.5
MIRM Mirum Pharmaceuticals, Inc. $5.1B -5.7 -703.0 -27.3 -38.1 44.0 3 BEARISH 13.6
CELC Celcuity Inc. $3.5B -16.8 -1433.7 1325.2 — — 3 BEARISH 59.4
VCRE Vicore Pharma Holding AB $2.6B — — — — — — BEARISH —
VRDN Viridian Therapeutics, Inc. $2.2B -5.5 -65.7 418.2 -44760.2 23220.3 4 BEARISH -8.8
MLYS Mineralys Therapeutics, Inc. $2.1B -5.6 -80.9 2274.6 — — 2 BEARISH -40.6
SRPT Sarepta Therapeutics, Inc. $1.9B -12.2 -9.5 -6.3 -1.2 -20.4 4 BEARISH -9.4
MESO Mesoblast Limited $1.8B -32.0 -9.9 -6.3 -25.2 599.2 5 BEARISH -13.5
GENB Generate Biomedicines, Inc. $1.8B -12.9 -28.2 -175.0 -1065.2 — 1 BEARISH —
GPCR Structure Therapeutics Inc. $1.6B -9.1 -20.2 -1134.3 — — 3 BEARISH 6.3
INVA Innoviva, Inc. $1.5B 4.2 36.7 15.0 -69.8 19.8 7 BEARISH 12.8
ASPHF Ascentage Pharma Group International $1.4B -6.4 -316.9 -211.0 -270.2 -29.1 1 BEARISH -58.3
DMRA Damora Therapeutics, Inc. $1.3B — — — — — — BEARISH —
TRAX First Tracks Biotherapeutics Inc $1.2B — — — — — — BEARISH —
ASCLF Ascletis Pharma Inc. $1.1B -11.7 -38.0 -12387.1 — -95.5 2 BEARISH -14.8
CRVS Corvus Pharmaceuticals, Inc. $920M -17.0 -35.4 -415.6 — — 4 BEARISH 50.1
GLUE Monte Rosa Therapeutics, Inc. $890M -4.8 -42.7 149.9 -483.9 -83.9 3 BEARISH 40.0
ALMS Alumis Inc. $850M -1.8 -93.6 2645.2 -8557.2 -63.1 2 BEARISH 68.7
SANA Sana Biotechnology, Inc. $800M -3.8 -152.9 -242.3 — — 3 BEARISH -21.9
GERN Geron Corporation $770M -12.0 -29.2 -74.1 -29.0 24.4 2 BEARISH -14.9
IVEVF Inventiva S.A. $760M -5.9 5541.6 502.1 -347346.6 -57.3 4 BEARISH 41.2
ATTO Attovia Therapeutics, Inc. $740M -18.5 -294.4 -1137.2 -4597.1 -50.5 4 BEARISH 308.8
OLMA Olema Pharmaceuticals, Inc. $720M -3.9 -52.7 585.3 — — 2 BEARISH -25.4
BLSM BlossomHill Therapeutics, Inc. $570M — — — — — — BEARISH —
PHAT Phathom Pharmaceuticals, Inc. $560M -5.4 26.4 8.9 -23.7 110.2 4 BEARISH -43.7
CTMX CytomX Therapeutics, Inc. $560M -5.7 -37.8 305.9 -1457.4 -87.0 2 BEARISH -23.6
CRMD CorMedix Inc. $560M 3.0 54.9 57.2 25.5 280.5 5 BEARISH -34.9
ALT Altimmune, Inc. $530M -3.5 -28.9 -43.1 — 55.0 4 BEARISH -20.4
ALLO Allogene Therapeutics, Inc. $520M -2.2 -42.4 -81.9 -919.8 — 5 BEARISH 21.0
ARVN Arvinas, Inc. $480M 39.0 1.6 -519.3 67.8 -15.0 4 BEARISH -18.8
AGMB AgomAb Therapeutics N.V. American Depositary Shares $420M — — — — — — BEARISH —
SPRY ARS Pharmaceuticals, Inc. $400M -1.9 -210.3 -424.3 -185.2 4.1 2 BEARISH -59.7
RLMD Relmada Therapeutics, Inc. $380M -3.9 -55.7 460.5 — — 3 BEARISH 66.7
KYTX Kyverna Therapeutics, Inc. $380M -2.1 -87.2 14267.8 — — 2 BEARISH 4.2
RGNX REGENXBIO Inc. $380M -2.0 -137.6 -368.4 21.0 12.0 2 BEARISH -23.9
PTCHF PureTech Health plc $380M 8.2 14.7 -97.5 1890.6 -3.3 5 BEARISH -0.7
BNTC Benitec Biopharma Inc. $310M -9.2 -33.2 1840.8 — — 3 BEARISH -29.6
LRMR Larimar Therapeutics, Inc. $310M -1.5 -139.6 590.9 — — 2 BEARISH -28.7

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

RAPP vs Benchmarks

ROIC
RAPP
3981.5
Industry
11.2
P/E Ratio
RAPP
-10.6
Sector
23.7
ROE
RAPP
-40.0
Sector
-28.8
Piotroski F
RAPP
4.0
Sector
4.0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms